# A Dose Escalation Study Using Collagenase Clostridium Histolyticum in the Treatment of Lipoma

> **NCT01613313** · PHASE2 · COMPLETED · sponsor: **Zachary Gerut** · enrollment: 14 (actual)

## Conditions studied

- Lipoma

## Interventions

- **DRUG:** Collagenase Clostridium Histolyticum

## Key facts

- **NCT ID:** NCT01613313
- **Lead sponsor:** Zachary Gerut
- **Sponsor class:** INDIV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-05
- **Primary completion:** 2013-09
- **Final completion:** 2013-10
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2016-10-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01613313

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01613313, "A Dose Escalation Study Using Collagenase Clostridium Histolyticum in the Treatment of Lipoma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01613313. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*